Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 3,495.00
-95.00 (-2.65%)
At close: Oct 1, 2026
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 23.27 billion as of October 2, 2026. Its market cap has decreased by -38.95% in one year.
Market Cap
23.27B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,495.00
ChartMarket Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 23.27B, a decrease of -71.91%. That is a compound annual growth rate of -26.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 23.27B | -30.65% |
| Dec 30, 2025 | 33.55B | 11.42% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korea Arlico Pharm | 34.64B |
| Pharmsville | 27.10B |
| HLscience | 26.53B |
| Daesung Microbiological Labs. | 23.03B |
| Seoul Pharma | 22.60B |
| BIFIDO | 21.43B |
| Hurum | 20.44B |
| Union Korea Pharm | 19.70B |